These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26486469)
21. Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene. Stumpf E; Masson H; Duquette A; Berthelet F; McNabb J; Lortie A; Lesage J; Montplaisir J; Brais B; Cossette P Arch Neurol; 2003 Sep; 60(9):1307-12. PubMed ID: 12975300 [TBL] [Abstract][Full Text] [Related]
22. Metabolic Enzyme Alterations and Astrocyte Dysfunction in a Murine Model of Alexander Disease With Severe Reactive Gliosis. Heaven MR; Herren AW; Flint DL; Pacheco NL; Li J; Tang A; Khan F; Goldman JE; Phinney BS; Olsen ML Mol Cell Proteomics; 2022 Jan; 21(1):100180. PubMed ID: 34808356 [TBL] [Abstract][Full Text] [Related]
23. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease. Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694 [TBL] [Abstract][Full Text] [Related]
24. Aberrant astrocyte Ca Saito K; Shigetomi E; Yasuda R; Sato R; Nakano M; Tashiro K; Tanaka KF; Ikenaka K; Mikoshiba K; Mizuta I; Yoshida T; Nakagawa M; Mizuno T; Koizumi S Glia; 2018 May; 66(5):1053-1067. PubMed ID: 29383757 [TBL] [Abstract][Full Text] [Related]
25. An infantile-juvenile form of Alexander disease caused by a R79H mutation in GFAP. Asahina N; Okamoto T; Sudo A; Kanazawa N; Tsujino S; Saitoh S Brain Dev; 2006 Mar; 28(2):131-3. PubMed ID: 16168593 [TBL] [Abstract][Full Text] [Related]
26. Alexander disease. Messing A Handb Clin Neurol; 2018; 148():693-700. PubMed ID: 29478608 [TBL] [Abstract][Full Text] [Related]
27. Elevated GFAP isoform expression promotes protein aggregation and compromises astrocyte function. Lin NH; Yang AW; Chang CH; Perng MD FASEB J; 2021 May; 35(5):e21614. PubMed ID: 33908669 [TBL] [Abstract][Full Text] [Related]
28. Recessively-Inherited Adult-Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene. Fu MH; Chang YY; Lin NH; Yang AW; Chang CC; Liu JS; Peng CH; Wu KLH; Perng MD; Lan MY Mov Disord; 2020 Sep; 35(9):1662-1667. PubMed ID: 32374915 [TBL] [Abstract][Full Text] [Related]
29. A novel mutation in the Casasnovas C; Verdura E; Vélez V; Schlüter A; Pons-Escoda A; Homedes C; Ruiz M; Fourcade S; Launay N; Pujol A J Med Genet; 2019 Dec; 56(12):846-849. PubMed ID: 31004048 [TBL] [Abstract][Full Text] [Related]
30. Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease. Hagemann TL; Powers B; Mazur C; Kim A; Wheeler S; Hung G; Swayze E; Messing A Ann Neurol; 2018 Jan; 83(1):27-39. PubMed ID: 29226998 [TBL] [Abstract][Full Text] [Related]
31. GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Li L; Tian E; Chen X; Chao J; Klein J; Qu Q; Sun G; Sun G; Huang Y; Warden CD; Ye P; Feng L; Li X; Cui Q; Sultan A; Douvaras P; Fossati V; Sanjana NE; Riggs AD; Shi Y Cell Stem Cell; 2018 Aug; 23(2):239-251.e6. PubMed ID: 30075130 [TBL] [Abstract][Full Text] [Related]
32. c.1289G>A (p.Arg430His) variant in the epsilon isoform of the GFAP gene in a patient with adult onset Alexander disease. Karp N; Lee D; Shickh S; Jenkins ME Eur J Med Genet; 2019 Apr; 62(4):235-238. PubMed ID: 30048824 [TBL] [Abstract][Full Text] [Related]
33. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hagemann TL; Boelens WC; Wawrousek EF; Messing A Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171 [TBL] [Abstract][Full Text] [Related]
34. Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes. Boyd MM; Litscher SJ; Seitz LL; Messing A; Hagemann TL; Collier LS J Neuroinflammation; 2021 Mar; 18(1):67. PubMed ID: 33685480 [TBL] [Abstract][Full Text] [Related]
35. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease. Mignot C; Delarasse C; Escaich S; Della Gaspera B; Noé E; Colucci-Guyon E; Babinet C; Pekny M; Vicart P; Boespflug-Tanguy O; Dautigny A; Rodriguez D; Pham-Dinh D Exp Cell Res; 2007 Aug; 313(13):2766-79. PubMed ID: 17604020 [TBL] [Abstract][Full Text] [Related]
36. [Alexander disease: diversity of cell population and interactions between neuron and glia]. Saito K; Shigetomi E; Koizumi S Nihon Yakurigaku Zasshi; 2021; 156(4):239-243. PubMed ID: 34193704 [TBL] [Abstract][Full Text] [Related]
37. Alexander disease - astrogliopathy considered as leukodystrophy - experience of an institution. Mierzewska H; Mierzewska-Schmidt M; Salomons GS; Dudzińska M; Szczepanik E Dev Period Med; 2016; 20(2):110-7. PubMed ID: 27442695 [TBL] [Abstract][Full Text] [Related]
38. A systematic review and meta-analysis of GFAP gene variants in Alexander disease. Grossi A; Rosamilia F; Carestiato S; Salsano E; Ceccherini I; Bachetti T Sci Rep; 2024 Oct; 14(1):24341. PubMed ID: 39420046 [TBL] [Abstract][Full Text] [Related]
39. Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in Alexander disease. Sosunov AA; Guilfoyle E; Wu X; McKhann GM; Goldman JE J Neurosci; 2013 Apr; 33(17):7439-50. PubMed ID: 23616550 [TBL] [Abstract][Full Text] [Related]
40. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Mignot C; Boespflug-Tanguy O; Gelot A; Dautigny A; Pham-Dinh D; Rodriguez D Cell Mol Life Sci; 2004 Feb; 61(3):369-85. PubMed ID: 14770299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]